期刊文献+

2-羟丙基-β-环糊精对卡维地洛增溶作用的研究 被引量:2

Study on the Solubilization of 2-Hydroxypropyl-β-cyclodextrin for Carvedilol
原文传递
导出
摘要 目的:考察不同pH条件下2-羟丙基-β-环糊精对卡维地洛的增溶作用,制备卡维地洛的2-羟丙基-β-环糊精包合物并对其进行结构表征。方法:以相溶解度法考察不同pH条件下2-羟丙基-β-环糊精对卡维地洛的增溶作用,采用溶液搅拌法制备包合物,并以差示扫描量热法、红外光谱法和X-射线衍射法对包合物进行结构表征。结果:相溶解度图呈A L型。相同pH条件下,卡维地洛溶解度随2-羟丙基-β-环糊精浓度增大而增大;相同2-羟丙基-β-环糊精浓度下,卡维地洛溶解度随pH增大而减小。差示扫描量热法、红外光谱和X-射线衍射法图谱均显示药物峰消失,表明卡维地洛与2-羟丙基-β-环糊精已形成包合物。结论:2-羟丙基-β-环糊精是卡维地洛的理想增溶剂。 Objective: To study the solubilization effect of 2-hydroxypropyl-β-cyclodextrin(2-HP-β-CD) on carvedilol under different pH values, and to prepare and characterize the carvedilol-2-HP-β-CD inclusion complex. Methods: The phase-solubility method was used to study the aqueous solubility of carvedilol under different pH values. The carvedilol-2-HP-β-CD inclusion complex was prepared by using solution- stirring method. In addition, the carvedilol-2-HP-β-CD inclusion complex was characterized by differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR) and X-ray diffractometry (XRD). Results: The phase-solubility diagrams of carvedilol were shown as AL type. The solubility of carvedilol increased with the increase of 2-HP-β-CD concentration under the same pH value. The solubility of carvedilol decreased with the increase of pH value under the same concentration of 2-HP-β-CD. The spectra of DSC, FTIR and XRD showed the disappearance of carvedilol peak, suggesting the formation of carvedilol-2-HP-β-CD inclusion complex. Conclusion: 2-HP-β-CD is an ideal solubilizer for carvedilol.
作者 冯丽杰 王柏
出处 《药学进展》 CAS 2013年第9期460-463,共4页 Progress in Pharmaceutical Sciences
关键词 2-羟丙基-Β-环糊精 卡维地洛 包合物 增溶作用 2-hydroxypropyl-β-cyclodextrin carvedilol inclusion complex solubilization effect
  • 相关文献

参考文献9

  • 1Dulin B, Abraham W T. Pharmacology of carvedilol [ J ]. Am J Cardiol,2004 ,93( 9A ) :3B-6B.
  • 2Kasim N A, Whitehouse M, Ramachandran C, et al. Mo- lecular properties of WHO essential drugs and provisional biopharmaceutical classification [ J ]. Mol Pharm, 2004, 1 ( 1 ) :85-96.
  • 3Wen X, Tan F, Jing Z, et al. Preparation and study the 1 : 2 inclusion complex of carvedilol with β-cyclodextrin[ J]. J Pharm Biomed Anal,2004,34(3 ) : 517-523.
  • 4Loftsson T, Duch~ne D. Cyclodextrins and their pharma- ceutical applications [ J ]. Int J Pharm, 2007,329 (1/2) : 1-11.
  • 5何忠贵.环糊精包合物技术[M].北京:人民卫生出版社,2008:29-35.
  • 6Bhutani S, Hiremath S N, Swamy P V, et al. Preparation and evaluation of inclusion complexes of carvedilol [ J ]. J Sci Ind Res India,2007,66(10) : 830-834.
  • 7周洁,蒋曙光,周建平.卡维地洛羟丙基-β-环糊精包合物的制备与评价[J].中国现代应用药学,2012,29(6):516-519. 被引量:10
  • 8Higuchi T K, Connors K A. Phase solubility techniques [J] .Adv Anal Chem Instrum,1965,4( 2 ) :212-217.
  • 9Stella V J, Rajewski R A. Cyclodextrins: their future in drug formulation and delivery [ J ]. Pharm Res, 1997,14 (5) :556-567.

二级参考文献6

  • 1Rajashree Hirlekar,Vilasrao Kadam.Preparation and characterization of inclusion complexes of carvedilol with methyl-β-cyclodextrin[J].Journal of Inclusion Phenomena and Macrocyclic Chemistry (-).2009(3-4)
  • 2Bril A,Slivjak M,Di Martino MJ,et al.Cardiopro-tective effects of carvedilol,a novel-adrenoceptor an-tagonist with vasodilating properties,in anesthetized minipigs:comparison with propranolol[].Cardiovascular Research.1992
  • 3Hamburger SA,Barone FE,Feuerstein GI,et al.Carvedilol(Kre-dex) reduces infarct size in a canine model of acute myocardial in farction[].Pharmacology.1991
  • 4Ruffolo H R,Jr Boyle P,Venuit R P,et al.Carvedilol(kredex) :a novel multiple action cardiovascular agent[].Drugs of Today.1991
  • 5Higuchi T,Connors KA.Phase solubility techniques[].Advances in Analytical Chemistry and Instrumentation.1965
  • 6Wang Zhi-xuan,Deng Ying-jie,Sun Su-ya,et al.Preparation of hydrophobic drugs cyclodextrin complex by lyophilization monophase solution[].Drug Development Research.2006

共引文献10

同被引文献7

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部